Dr Reddy’s Lab rolls out Omeprazole delayed-release tablets in US market. Dr Reddy’s Laboratories Tuesday said it has launched Omeprazole delayed-release tablets, used to treat frequent heartburn, in the US market.
Source: www.devdiscourse.com
Reddy’s Laboratories announces the launch of its Omeprazole Delayed-Release 20mg Tablets in the US market. Omeprazole is known to help treat frequent heartburn occurring two or more days per week in adults. This new drug is an over-the-counter (OTC) store-brand equivalent to the Prilosec OTC Tablets 20 mg which are currently used as a proton pump inhibitor. Prilosec is a registered trademark of AstraZeneca AB.
